Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% |
|
-.--% | -.--% |
Jun. 20 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday | MT |
Jun. 18 | Cara Therapeutics to Idle 70% Workforce, Explore Alternatives After Scrapping Notalgia Paresthetica Program | MT |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Difelikefalin-based Product
100.0
%
| 42 | 100.0 % | 21 | 100.0 % | -49.92% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 42 | 100.0 % | 21 | 100.0 % | -49.92% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 18-08-05 | |
Ryan Maynard
DFI | Director of Finance/CFO | 54 | 22-09-11 |
Scott Terrillion
CMP | Compliance Officer | 61 | 16-10-31 |
Iris Francesconi
IRC | Investor Relations Contact | - | - |
Beth Weinberg
LAW | General Counsel | - | - |
Richard Makara
AUD | Comptroller/Controller/Auditor | 54 | 14-09-30 |
Eric J. Vandal
PRN | Corporate Officer/Principal | - | 14-06-01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Vogelbaum
CHM | Chairman | 60 | 10-06-30 |
Jeffrey Ives
BRD | Director/Board Member | 73 | 14-07-15 |
Helen Boudreau
BRD | Director/Board Member | 58 | 23-08-01 |
Chief Executive Officer | 54 | 18-08-05 | |
Susan Shiff
BRD | Director/Board Member | 63 | 20-06-25 |
Lisa von Moltke
BRD | Director/Board Member | 65 | 22-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,675,954 | 46,337,062 ( 84.75 %) | 0 | 84.75 % |
Company contact information
CARA Therapeutics, Inc.
400 Atlantic Street Suite 500
06901, Stamford
+203 406 3700
http://www.caratherapeutics.com![address Cara Therapeutics, Inc.(69C)](https://cdn.zonebourse.com/static/address/149356557.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.95% | 97.7B | |
+5.66% | 41.43B | |
-12.80% | 32.85B | |
+80.99% | 29.33B | |
-15.53% | 15.47B | |
-8.70% | 12.89B | |
-12.22% | 11.51B | |
+183.25% | 10.74B | |
-55.41% | 8.97B |
- Stock Market
- Equities
- CARA Stock
- 69C Stock
- Company Cara Therapeutics, Inc.